Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Haematologica|September 26, 2024
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanismDelphine Simon, Mathilde Leclercq, Bérangère Joly, et al.
Arthritis and Rheumatism|April 29, 2008
Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndromeLaurence Fardet, Paul Coppo, Adrien Kettaneh, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2025
Successful use of recombinant ADAMTS13 in a pregnant patient with immune-mediated thrombotic thrombocytopenic purpuraRaphael Cauchois, Pascale Poullin, Alexandre Hertig, et al.
Journal of Autoimmunity|February 10, 2015
The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive reviewEtienne Ghrenassia, Nihal Martis, Julien Boyer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008
Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate lossHelene François, Paul Coppo, Jean-Philippe Hayman, et al.
Medicine|September 30, 2016
Efficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature reviewClemence Deville, Cyril Garrouste, Paul Coppo, et al.
Medicine|February 3, 2018
Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case reportMarine Freist, Cyril Garrouste, Nora Szlavik, et al.
European Journal of Internal Medicine|November 5, 2013
Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a proteinPaul Coppo, Isabelle Henry-Dessailly, Jacques Rochette, et al.
Research and Practice in Thrombosis and Haemostasis|January 22, 2026
Monitoring ADAMTS-13 conformation in immune-mediated thrombotic thrombocytopenic purpura: toward personalized managementBérangère S Joly, Elien Roose, Charlotte Dekimpe, et al.
Toxins|April 30, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care ManagementBenoit Travert, Cédric Rafat, Patricia Mariani, et al.
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Haematologica|September 26, 2024
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanismDelphine Simon, Mathilde Leclercq, Bérangère Joly, et al.
Arthritis and Rheumatism|April 29, 2008
Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndromeLaurence Fardet, Paul Coppo, Adrien Kettaneh, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2025
Successful use of recombinant ADAMTS13 in a pregnant patient with immune-mediated thrombotic thrombocytopenic purpuraRaphael Cauchois, Pascale Poullin, Alexandre Hertig, et al.
Journal of Autoimmunity|February 10, 2015
The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive reviewEtienne Ghrenassia, Nihal Martis, Julien Boyer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008
Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate lossHelene François, Paul Coppo, Jean-Philippe Hayman, et al.
Medicine|September 30, 2016
Efficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature reviewClemence Deville, Cyril Garrouste, Paul Coppo, et al.
Medicine|February 3, 2018
Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case reportMarine Freist, Cyril Garrouste, Nora Szlavik, et al.
European Journal of Internal Medicine|November 5, 2013
Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a proteinPaul Coppo, Isabelle Henry-Dessailly, Jacques Rochette, et al.
Research and Practice in Thrombosis and Haemostasis|January 22, 2026
Monitoring ADAMTS-13 conformation in immune-mediated thrombotic thrombocytopenic purpura: toward personalized managementBérangère S Joly, Elien Roose, Charlotte Dekimpe, et al.
Toxins|April 30, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care ManagementBenoit Travert, Cédric Rafat, Patricia Mariani, et al.
Pageof 20